Mink Long Term Debt from 2010 to 2025

INKT Stock

USD 8.95 0.15 1.65%

Mink Therapeutics Long Term Debt yearly trend continues to be comparatively stable with very little volatility. Long Term Debt will likely drop to about 38.8 M in 2025. Long Term Debt is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. View All Fundamentals

Long Term Debt

First Reported

2010-12-31

Previous Quarter

50.4 M

Current Value

38.8 M

Quarterly Volatility

8.9 M

Credit Downgrade

Yuan Drop

Covid

Check Mink Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 672.1 K, Depreciation And Amortization of 118.7 K or Interest Expense of 216.6 K, as well as many indicators such as Price To Sales Ratio of 0.35, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Mink financial statements analysis is a perfect complement when working with Mink Therapeutics Valuation or Volatility modules.

Check out the analysis of Mink Therapeutics Correlation against competitors.

For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Latest Mink Therapeutics' Long Term Debt Growth Pattern

Below is the plot of the Long Term Debt of Mink Therapeutics over the last few years. Long-term debt is a debt that Mink Therapeutics has held for over one year. Long-term debt appears on Mink Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Mink Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Mink Therapeutics' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mink Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Long Term Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Long Term Debt

Timeline

Mink Long Term Debt Regression Statistics

	Arithmetic Mean	33,277,221
	Geometric Mean	32,258,498
	Coefficient Of Variation	26.76
	Mean Deviation	8,108,524
	Median	26,790,402
	Standard Deviation	8,906,010
	Sample Variance	79.3T
	Range	23.6M
	R-Value	0.81
	Mean Square Error	29T
	R-Squared	0.66
	Significance	0.0001
	Slope	1,518,649
	Total Sum of Squares	1189.8T

Mink Long Term Debt History

	2025	38.8 M
	2024	50.4 M
	2020	43.8 M

Other Fundumenentals of Mink Therapeutics

	Short Long Term Debt Total
	Long Term Debt To Capitalization

Mink Therapeutics Long Term Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Capital Surpluse
Total Assets		0.91	0.76	0.03	-0.85	-0.41	0.42	0.56	-0.58	-0.6	0.89	1.0	0.52	0.96	0.03	0.52	0.35	0.03
Total Stockholder Equity	0.91		0.93	-0.14	-0.98	-0.6	0.53	0.56	-0.58	-0.87	0.71	0.9	0.71	0.88	-0.14	0.71	0.55	-0.14
Net Tangible Assets	0.76	0.93		-0.41	-0.98	-0.82	0.65	0.7	-0.72	-0.94	0.44	0.74	0.89	0.65	-0.41	0.89	0.73	-0.41
Current Deferred Revenue	0.03	-0.14	-0.41		0.3	0.6	-0.41	-0.39	0.46	0.37	0.29	0.05	-0.53	0.19	1.0	-0.53	-0.39	1.0
Net Debt	-0.85	-0.98	-0.98	0.3		0.76	-0.67	-0.69	0.71	0.91	-0.57	-0.84	-0.84	-0.77	0.3	-0.84	-0.69	0.3
Retained Earnings	-0.41	-0.6	-0.82	0.6	0.76		-0.86	-0.86	0.89	0.73	0.04	-0.39	-0.94	-0.21	0.6	-0.94	-0.92	0.6
Accounts Payable	0.42	0.53	0.65	-0.41	-0.67	-0.86		0.8	-0.8	-0.59	0.0	0.4	0.82	0.24	-0.41	0.82	0.9	-0.41
Long Term Debt	0.56	0.56	0.7	-0.39	-0.69	-0.86	0.8		-0.97	-0.51	0.16	0.54	0.88	0.32	-0.39	0.88	0.85	-0.39
Net Receivables	-0.58	-0.58	-0.72	0.46	0.71	0.89	-0.8	-0.97		0.49	-0.18	-0.56	-0.84	-0.34	0.46	-0.84	-0.79	0.46
Total Liab	-0.6	-0.87	-0.94	0.37	0.91	0.73	-0.59	-0.51	0.49		-0.32	-0.58	-0.83	-0.55	0.37	-0.83	-0.71	0.37
Net Invested Capital	0.89	0.71	0.44	0.29	-0.57	0.04	0.0	0.16	-0.18	-0.32		0.9	0.11	0.96	0.29	0.11	-0.08	0.29
Total Current Assets	1.0	0.9	0.74	0.05	-0.84	-0.39	0.4	0.54	-0.56	-0.58	0.9		0.5	0.97	0.05	0.5	0.33	0.05
Capital Stock	0.52	0.71	0.89	-0.53	-0.84	-0.94	0.82	0.88	-0.84	-0.83	0.11	0.5		0.34	-0.53	1.0	0.94	-0.53
Net Working Capital	0.96	0.88	0.65	0.19	-0.77	-0.21	0.24	0.32	-0.34	-0.55	0.96	0.97	0.34		0.19	0.34	0.17	0.19
Short Term Debt	0.03	-0.14	-0.41	1.0	0.3	0.6	-0.41	-0.39	0.46	0.37	0.29	0.05	-0.53	0.19		-0.53	-0.39	1.0
Common Stock	0.52	0.71	0.89	-0.53	-0.84	-0.94	0.82	0.88	-0.84	-0.83	0.11	0.5	1.0	0.34	-0.53		0.94	-0.53
Property Plant Equipment	0.35	0.55	0.73	-0.39	-0.69	-0.92	0.9	0.85	-0.79	-0.71	-0.08	0.33	0.94	0.17	-0.39	0.94		-0.39
Capital Surpluse	0.03	-0.14	-0.41	1.0	0.3	0.6	-0.41	-0.39	0.46	0.37	0.29	0.05	-0.53	0.19	1.0	-0.53	-0.39

Click cells to compare fundamentals

About Mink Therapeutics Financial Statements

Mink Therapeutics shareholders use historical fundamental indicators, such as Long Term Debt, to determine how well the company is positioned to perform in the future. Although Mink Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Mink Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Mink Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Short and Long Term Debt Total	50.4 M	38.8 M
Long Term Debt	50.4 M	38.8 M
Long Term Debt To Capitalization	(5.01)	(5.27)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mink Long Term Debt from 2010 to 2025

Latest Mink Therapeutics' Long Term Debt Growth Pattern

Mink Long Term Debt Regression Statistics

Mink Long Term Debt History

Other Fundumenentals of Mink Therapeutics

Mink Therapeutics Long Term Debt component correlations

About Mink Therapeutics Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Mink Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY